dopium 7OH Flavored Tablets 50mg x 5ct
dopium 7OH Flavored Tablets 50mg x 5ct are low-volume, high-precision 7‑hydroxymitragynine chewable tablets designed for adult, advanced users who want structured 50mg servings with flavor-forward profiles and fast-acting, chewable convenience. This is a botanical specimen, and the description below is for illustrative purposes only.
Product overview
Each pack includes 5 chewable tablets, each pre-dosed at 50mg of 7‑Hydroxymitragynine, for a total of 250mg per pack. Tablets are designed with a suggested serving size of ½ tablet, giving 25mg per serving, which helps support more cautious, stepwise intake while still maintaining clear milligram labeling. The tablets are soft and easy to chew, and many adult users report the chewable format may feel faster in onset than non-chewable formats when used as directed.
Flavor lineup
All flavors share the same 50mg‑per‑tablet strength and 25mg‑per‑½‑tablet serving structure, but each brings its own distinct profile:
- Green Apple: Crisp, tart green-apple bite with a clean, refreshing finish—classic green apple tang balanced by enough sweetness to stay smooth and easy to chew without feeling harsh.
- Peach: Soft, slightly sweet, and mellow, with a gentle peach note that feels relaxed and comforting rather than candy-heavy—ideal if you like subtle, easygoing flavors.
- Watermelon: Smooth, lightly sweet, and refreshing, with a clean, mellow fruit taste that doesn’t overpower the palate—good for those who prefer lighter, relaxed profiles.
- Grape Slushie: Smooth, nostalgic grape with a cool slushie vibe; more rounded than sharp, offering soft sweetness that avoids feeling artificial or overwhelming.
- Cotton Candy: Light, sweet, and smooth with a soft sugar-like character; not syrupy or heavy, just a gentle sweetness that keeps each chew easy and pleasant.
- Blue Razz: Bright, candy-style blue raspberry with a mix of sweetness and light tang—bold enough to feel fun while still staying easy on the palate, like a familiar fruity treat.
Across flavors, the tablets are formulated so the taste stays consistent from the first tablet to the last, helping mask natural bitterness while keeping the experience predictable and repeatable.
- Strength: 50mg 7‑Hydroxymitragynine per tablet.
- Pack: 5 tablets per pack = 250mg total.
- Serving: Suggested serving size ½ tablet (25mg); advanced users may adjust only as labeled and as tolerated.
- Format: Chewable tablet—no water required, no powders, no measuring.
The pre-dosed, chewable format is built for accuracy and convenience: users don’t have to weigh or scoop, and the ½‑tablet serving structure offers a clear way to start low and remain in control. The compact, discreet tablets are easy to carry at home, work, or while traveling.
Safety and critical warnings
These tablets contain 7‑Hydroxymitragynine (7‑OH), a highly potent kratom-derived alkaloid, and the product is intended only for responsible adult use:
- Age: Keep out of reach of children; for adults 21+ only per typical brand guidance.
- Not FDA-approved: 7‑OH is not approved by the FDA for therapeutic use, and this product is not intended to diagnose, treat, cure, or prevent any disease.
- Habit-forming risk: 7‑OH may be habit forming; those with a history of addiction or dependency should consult a physician and may wish to avoid 7‑OH products altogether.
- Do not mix with other substances: Do not use with alcohol, nicotine, cannabinoids, other botanical products, psychoactive or intoxicating substances, or illicit drugs.
- Medical conditions & medications: Do not use if you have heart or liver disease, high blood pressure, or other significant health issues, or if you use prescription medications, OTC drugs, or supplements except under direct physician supervision.
- Pregnancy & breastfeeding: Do not use if pregnant, may become pregnant, or are breastfeeding.
- Impairment: Avoid operating machinery, driving, or performing dangerous activities after use, as 7‑OH can impair judgment and motor skills.
- Product integrity: Do not use if the packaging is damaged or opened before first use.
If any adverse effects occur, users should seek immediate medical attention and discontinue use.
These statements have not been evaluated by the United States Food and Drug Administration.
US
